Join to View Full Profile
7171 N Dale Mabry HwyTampa, FL 33614
Dr. Padron is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Osvaldo Padron is a Urologist based in Tampa, Florida with subspecialties in Female Urology/Pelvic Medicine & Reconstructive Surgery. He undertook his residency in Surgery and Urology at the University of Miami/Jackson Health System after graduating from the University of Miami Leonard M. Miller School of Medicine in 1989. Dr. Padron is a noted author in his field with a number of key publications, including work in The Journal of Urology and Neurourology and Urodynamics, with several of these serving as highly cited pieces in their respective journals. His participation in a series of clinical trials, including the Prospective US Radiofrequency SUI Trial and the BlueWind RENOVA iStim™ System for the Treatment of OAB, underlines his contribution to advancing urological treatment. He is a Meaningful Use Stage 1 Certification recipient from the Centers for Medicare & Medicaid Services and a Fellow of the American College of Surgeons.
Education & Training
University of Miami/Jackson Health SystemResidency, Urology, 1991 - 1995- University of Miami/Jackson Health SystemResidency, Surgery, 1989 - 1991
University of Miami Leonard M. Miller School of MedicineClass of 1989
Certifications & Licensure
FL State Medical License 1990 - 2026
OH State Medical License 1995 - 1996
American Board of Urology Urology- American Board of Urology Female Pelvic Medicine and Reconstructive Surgery
Awards, Honors, & Recognition
- Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2012
- Fellow (FACS) American College of Surgeons
Clinical Trials
- BlueWind RENOVA iStim™ System for the Treatment of OAB Start of enrollment: 2019 Jun 12
- Prospective US Radiofrequency SUI Trial Start of enrollment: 2021 Jan 11
Publications & Presentations
PubMed
- Preservation of sexual function with Optilume-a novel treatment for lower urinary tract symptoms secondary to benign prostatic hyperplasia.Olivia Copelan, Jared Moss, Sheldon Freedman, Karl Coutinho, Dean Elterman
The Journal of Sexual Medicine. 2025-04-08 - Two-Year Efficacy and Safety Outcomes of the Pivotal OASIS Study Using the Revi System for Treatment of Urgency Urinary Incontinence.John P F A Heesakkers, Philip Toozs-Hobson, Suzette E Sutherland, Alex Digesu, Cindy L Amundsen
The Journal of Urology. 2025-03-01 - 2 citationsA prospective study to assess the effectiveness and safety of the BlueWind System in the treatment of patients diagnosed with urgency urinary incontinence.John P F A Heesakkers, Philip Toozs-Hobson, Suzette E Sutherland, Alex Digesu, Cindy L Amundsen
Neurourology and Urodynamics. 2024-09-01
Press Mentions
First Patient in the RESTORE Clinical Study of Revi™ System for Urge Urinary Incontinence Treated in Tampa, FloridaFebruary 29th, 2024
Professional Memberships
- Member
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
